Stephen Boyer Email and Phone Number
Stephen Boyer work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Stephen Boyer personal email
Stephen Boyer phone numbers
Regulatory leader combining global development experience in small molecule, biologic, and gene therapy modalities together with comprehensive non-clinical drug discovery expertise.Global regulatory team leader, project leader of multifunctional drug discovery teams, chemistry team leader for development and research programs that achieved project milestones and provided key deliverables.Recognized manager and mentor of regulatory leaders, Ph.D. scientists, and lab associates,Broadly experienced managing and influencing in matrix organizations and with external partners; able to analyze and effectively communicate complex program issues and provide data-driven solutions. Led submissions, including: preIND, IND, PIP, PSP, China CTA, NDA/MAA dossier planning.Prepared for, participated in meetings with FDA (preIND, Clinical Hold, Type C, EOP2), EU (EMA, national SA), PMDA (EOP2). Worked in neurology, immunology, oncology, virology, antibiotic, gastroenterology, cardiovascular, chronic kidney disease, and pulmonary therapeutic areas
-
Principal ConsultantRegulatory Science Insights, LlcCambridge, Ma, Us
-
Vice President, Head Of Regulatory StrategyAlkermes Nov 2023 - PresentDublin, Ie -
Vice President, Head Of Regulatory Affairs And QualityPalleon Pharmaceuticals Jun 2022 - Oct 2023Waltham, Massachusetts, UsResponsible for company regulatory strategy and operations; line manager of the Director Quality AssuranceProgram Development Lead for a team developing a targeted bifunctional sialidase for the treatment of solid tumors. Accountable for overall program strategy and coordination with international partner. Standing member of Joint Steering Committee for collaboration and project portfolio. -
Vice President, Head Of Regulatory Affairs And QualityLogicbio Therapeutics Mar 2021 - Jun 2022Lexington, Massachusetts, UsLed the regulatory and quality functions for the organization. As head of regulatory, developed a global regulatory strategy for the lead program and led a successful rapid response to a clinical hold. Also built a strong foundation for global regulatory submissions and safety reporting. As head of quality, worked with a network of consultants to migrate from a paper to an electronic QMS: performed a gap analysis, revised all existing written procedures, developed new SOPs, and launched new system. Also responsible for audit program and vendor qualification, stability program, and quality strategy. -
Vice President, Head Of RegulatoryBoston Pharmaceuticals 2020 - 2021Cambridge, Ma, UsLeader of the team responsible for Regulatory Strategy, Regulatory CMC, and Regulatory Operations for all of Boston Pharmaceuticals' programs. -
Executive Director, Regulatory AffairsBoston Pharmaceuticals 2018 - 2020Cambridge, Ma, UsRegulatory lead for 6 early development programs in gastrointestinal, antibiotic, antiviral and pulmonary indications. Delivered 2 successful IND submissions that enabled on time clinical study start. Acted as point of contact for and led interactions with Biomedical Advanced Research and Development Authority (BARDA) and Defense Threat Reduction Agency (DTRA) for several anti-infective programs. Conducted regulatory assessments as part of in-licensing due diligence teams. -
Director, Head Of Early Global Regulatory StrategyBiogen 2017 - 2018Cambridge, Ma, UsLed Early Global Regulatory Sciences (EGRS) group. Allocated resources for a portfolio of 27 early stage programs, managed group of 5 Early Global Regulatory Lead direct reports, represented regulatory function in leadership forums, strengthened partnerships within EGRS and with Biogen stakeholders.Global Regulatory Lead for neuromuscular gene therapy. Collaborated with academic partner and drove key elements of preIND meeting, clinical strategy, and IND strategy. Also provided regulatory leadership for a pre-proof of concept Parkinson's Disease program. -
Associate Director, Early Global Regulatory Strategy LeadBiogen 2015 - 2017Cambridge, Ma, UsRepresented regulatory function across a broad portfolio of 11 early development assets in neurology (AD, PD, MS), neuromuscular disorders, ophthalmology and immunology. Developed global regulatory strategy for all PD assets, with an emphasis on enabling critical clinical development tools: novel endpoints (movement, imaging, cognition), devices. Led successful IND submission, enabling an on-time Phase 1 start. Provided regulatory leadership on team challenged to create novel endpoint model. Coordinated a briefing package and PRO dossier that incorporated the patient perspective into choice of Clinical Outcome Assessments (COAs).Acted as Global Regulatory Lead for all Biogen gene and cell therapy programs. Worked with external IND sponsors on regulatory strategy and provided ongoing guidance to Biogen development teams. -
Associate Director, Global Regulatory Team LeaderBristol-Myers Squibb, Wallingford, Connecticut 2012 - Apr 2015Lawrence Township, Nj, UsResponsible for development and implementation of regulatory strategy for HCV-TRIO regimen. Represented regulatory on a registrational stage development team, matrix managed a Global Regulatory Team, oversaw implementation of global submission plan, including NDA/MAA/JNDA submission strategy. Supported preparation for and participated in global regulatory meetings. Led several submission efforts, including a team that provided an accepted, globally aligned PIP and PSP. -
Global Regulatory Strategy ManagerBristol-Myers Squibb, Wallingford, Connecticut 2011 - 2012Lawrence Township, Nj, UsRepresented Global Regulatory Sciences on Early Development Teams for diabetes and virology assets. Led successful IND submission, contributed to global Health Authority meetings, drove Agency submissions, and led response teams. Authored global regulatory plans and supported creation of global submission plans for internal regulatory reviews at project milestones. -
Principal ScientistBoehringer-Ingelheim Pharmaceuticals 2007 - 2011Ingelheim Am Rhein, Rhineland-Palatinate, DeResearch Project Leader for drug discovery projects in cardiovascular and chronic kidney disease therapeutic areas. Matrix managed large cross-functional teams, including international CRO resources. Also defined project intellectual property strategies and publication plans, and acted as liaison for an external collaboration.Represented chemistry department on Atherosclerosis TA Working Group, a cross-functional team providing ongoing strategic input into new target proposals to research leadership team -
Senior Research Scientist IiBayer Pharmaceuticals Corporation 1998 - 2007Leverkusen, North Rhine-Westphalia, DeResearch Project Leader of several multidisciplinary lead identification and optimization teams, including global teams based both in Germany and the US. Primary representative responsible for developing, communicating and defending team strategy, including timelines, resource allocation, and probability of success.Designed and synthesized kinase inhibitors in oncology. Laboratory contributed significantly to the discovery of Stivarga (regorafenib) and the clinical candidate telatinib.Selected as a two-year transferee to Bayer HealthCare, Germany. Led chemistry team that delivered pre-clinical candidate for urology. Facilitated project prioritization during transfer of urology portfolio from Japan to Germany.
Stephen Boyer Skills
Stephen Boyer Education Details
-
University Of California, BerkeleyNatural Product Synthesis -
University Of Illinois Urbana-ChampaignChemistry
Frequently Asked Questions about Stephen Boyer
What company does Stephen Boyer work for?
Stephen Boyer works for Regulatory Science Insights, Llc
What is Stephen Boyer's role at the current company?
Stephen Boyer's current role is Principal Consultant.
What is Stephen Boyer's email address?
Stephen Boyer's email address is st****@****als.com
What is Stephen Boyer's direct phone number?
Stephen Boyer's direct phone number is (781) 464*****
What schools did Stephen Boyer attend?
Stephen Boyer attended University Of California, Berkeley, University Of Illinois Urbana-Champaign.
What skills is Stephen Boyer known for?
Stephen Boyer has skills like Drug Discovery, Drug Development, Medicinal Chemistry, Regulatory Affairs, Pharmaceutical Industry, Clinical Development, Toxicology, Regulatory Submissions, Oncology, Life Sciences, Lifesciences, Clinical Trials.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial